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Conclusions: SNPs in IL-6 572 and RANTES gene affect the
chronic hepatitis B infection independently and jointly. The
IL-6 572GG and RANTES In1.1TC are the high risks of CHB.
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Objective: S100A11 is a putative tumor suppressor gene.
This study aimed to uncover the function that S100A11
protein playing on BEL-7402 cell growth and investigate
the effect of transcriptional regulation of HBx on S100A11
gene.
Methods: HBx recombinant expression plasmid and
S100A11-p promoter reporter vectors were constructed.
After transfection into BEL-7402 cell, reporter gene
expression was detected by luciferase. The expression
vector S100A11 (experimental group) was constructed
and transfected BEL-7402 cells. Stabilized expression was
screened. The rate in BEL-7402 S phase is detected by
Flow Cytometry (FCM). Living cell rate of two groups were
detected by Celltiter-Glo luminescent cell viability assay.
Results: Compared with the group which cotransfected
with pGL4.10-S100A11-promoter and pcDNA3.1( )-HBX, the
promoter activity of the group which cotransfected with
pcDNA3.1( ) and pGL4.10-S100A11-promoter was obviously
decreased. Fluorescein reporters is 1/3 fold lower. In control
group and mocked transfected group, BEL-7402 cells were
detected by FCM and S phase cell population in each group
was 26.49±1.94% and 30.42±1.62% respectively. Celltiter-
Glo luminescent cell viability assay showed that after
36 hour of transfection, the proliferation was obviously
decreased in experimental group than control.
Conclusion: S100A11 has obvious growth inhibiting effect on
BEL-7402 cell line. HBxAg has inhibiting effect on promoter
activity of S100A11 gene, indicating that HBV may play a role
of carcinogenesis by regulating anti-oncogene S100A11.
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Objective: Clone and identiﬁcation of human gene 5
transactivated by HBxAg protein (XTP5) by constructing
a cDNA subtractive library with suppression subtractive
hybridization (SSH) technique were investigated, which
indicated its modulation function. Moreover, Suppression
subtractive hybridization (SSH) and bioinformatics
techniques were used for screening and cloning of the
target genes transactivated by XTP5 protein.
Methods:The mRNA was isolated from HepG2 cells
transfected pcDNA3.1( )-XTP5 and pcDNA3.1( ) empty
vector, respectively, and SSH method was employed to
analyze the differentially expressed DNA sequence between
the two groups. After restriction enzyme RsaI digestion,
small sizes cDNAs were obtained. Then tester cDNA was
divided into two groups and ligated to the speciﬁc
adaptor 1 and adaptor 2, respectively. After tester cDNA
was hybridized with driver cDNA twice and underwent
polymerase chain reaction (PCR) twice and then was
subcloned into pGEM-T easy plasmid vectors to set up the
subtractive library. Ampliﬁcation of the library was carried
out with E. coli strain DH5a. The cDNA was sequenced and
analyzed in GenBank with Blast search after PCR.
Results: The subtractive library of genes transactivated
by XTP5 was constructed successfully. The ampliﬁed
library contains 101 positive clones. Colony PCR showed
that these clones contain 200 1000bp inserts. Sequence
analysis was performed in 28 clones, at random, and the
full length sequences were obtained with bioinformatics
method. Altogether 18 coding sequences were gotten, which
consisted of 14 known and 4 unknown ones.
Conclusion: The obtained sequences transactivated by
XTP5, coded different proteins and played important roles
in cell growth and metabolism, energy synthesis and
metabolism, material transport and signal transduction. This
ﬁnding brought some new clues not only for studying the
biological functions of mHA-8, but also for exploring HBV
infection mechanism.
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Background and Objectives: Chinese herb (CB) consisting
of 13 ingredients + Adefovir Dipivoxi (AD) made about 29%
chronic HBV patients’ HBVDNA levels be less than 1000
copies/ml and get HBeAg/anti-HBe seroconversions for 130
weeks treatment. This study shows that improving previous
CB prescription and personality treatment may suppress
HBV infection for some CHB patients in short-term.
Methods: The improved main prescription consists of 15
herb ingredients, which is used for all CHB patients. The
sub-prescription consist of 4 5 different herb ingredients,
which is used for CHB patients with different symptoms.
The net weight of each of the improved traditional
Chinese herb prescriptions (ITCPs) is about 450g-600g. They
will be decocted for patients’ taking. The CHB patients
took the ITCPs two times each day. When a patient’s
serum HBeAg has been lower than 70S/CO, he will take
AD (10mg/day additionally. Each selected CHB patient
has baseline HBVDNA >1e5 copies/mL, HBeAg >100S/CO,
ALT>ULN.
Results: Among 88 CHB patients, there are about 8% (7/88)
patients whose HBVDNA <1000cp/mL and obtained, and/or
HBeAg/anti-HBe seroconversion in half a year’s therapy.
Conclusion: The short-Term Suppressing HBV Infection can
be achieved to the CHB patients who have high baseline ALT
(>8ULN), or low ALT (>1ULN and <1.5ULN) and low HBVDNA
(<5e6 cp/mL). The analysis to the clinic data shows that
the main anti-HBV infection function of the ITCPs is to raise
and/ or activate patients immune responds and not only
blocks the replications of patients’ HBVDNA.
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